retatrutide phase 2 obesity trial results ⭐️topline from TRIUMPH-1, a 3 clinical evaluating #retatrutide, an investigational GIP / GLP-1 / glucagon triple hormone receptor agonist, in adults with or “overweight” Eloralintide vs Retatrutide: Data Compared

Robert Kushner: Yeah, it's a very good question

Immunofluorescence staining targeted neurogenic markers including nestin, GAP43, -tubulin III, and doublecortin

Recent labs and medical history

If you already have a thyroid nodule: Benign nodules are not a contraindication Routine surveillance should continue as recommended Screening ultrasounds are not required just because you start a GLP-1 medication A physical exam and baseline thyroid labs are usually sufficient

GLP 1 medications directly improve insulin sensitivity by helping the body use insulin more efficiently, reducing insulin spikes after meals, and creating more stable blood sugar levels